In Brief: Sequus
Executive Summary
Sequus: Craig Henderson, MD, named CEO and Scott Minick named president and chief operating officer of the renamed biotech Liposome Technologies. Chairman and CEO Nick Arvanitidis, PhD, is retiring July 1. Henderson comes to Sequus from the University of California at San Francisco and served on FDA's Oncologic Drugs Advisory Committee from 1989-92. Minick was formerly interim president of Oncotherapeutics in Princeton, N.J...